PGA
ABBV icon

Premia Global Advisors’s AbbVie ABBV Stock Holding History

Premia Global Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,594
Closed -$289K – 51
2019
Q1 		$289K Buy
+3,594
New +$294K 0.29% 70
2018
Q2 		– Sell
-3,594
Closed -$339K – 176
2018
Q1 		$339K Buy
3,594
+1,990
+124% +$219K 0.29% 45
2017
Q4 		$155K Buy
+1,604
New +$151K 0.15% 156

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Premia Global Advisors's ABBV Position: Q2 2019 in Review

Premia Global Advisors sold out of AbbVie (ABBV) in Q2 2019, closing a stake of 3,594 shares — an estimated $289K sold.

Premia Global Advisors first reported a position in ABBV in Q4 2017 and held it in 3 quarters. The position peaked at $339K in Q1 2018. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

  • Premia Global Advisors reported no remaining AbbVie position as of Q2 2019 after selling out during the quarter.
  • Premia Global Advisors sold 3,594 AbbVie shares in Q2 2019, an estimated $289K.
  • Premia Global Advisors first reported a position in AbbVie in Q4 2017 and held it in 3 quarters.
  • Premia Global Advisors's AbbVie position peaked at $339K in Q1 2018.
  • 2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Premia Global Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.